Financials TATA Health International Holdings Limited
Equities
1255
KYG7998M1033
Apparel & Accessories Retailers
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 HKD | -.--% | -.--% | -6.25% |
Jun. 05 | TATA Health International Holdings Limited Announces Delay in Publication of 2023 Annual Results | CI |
Apr. 19 | Tata Health International Further Delays Announcement of 2023 Final Results | MT |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 656 | 502.9 | 774.7 | 597.1 | 386.1 | 213.7 |
Enterprise Value (EV) 1 | 774.6 | 544 | 841.3 | 654.4 | 391.8 | 231.1 |
P/E ratio | -15.1 x | -285 x | -12.7 x | -3.93 x | -6.07 x | 22.2 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.36 x | 1.4 x | 2.27 x | 3.84 x | 2.4 x | 1.48 x |
EV / Revenue | 1.6 x | 1.52 x | 2.46 x | 4.21 x | 2.43 x | 1.6 x |
EV / EBITDA | -22.6 x | 133 x | -25.7 x | -4.47 x | -6.9 x | -7.98 x |
EV / FCF | 11 x | 121 x | 14.8 x | 16.8 x | 7.95 x | -14.8 x |
FCF Yield | 9.09% | 0.82% | 6.76% | 5.94% | 12.6% | -6.75% |
Price to Book | 3.95 x | 2.29 x | 4.82 x | 59.2 x | 16.8 x | 6.35 x |
Nbr of stocks (in thousands) | 200,000 | 214,000 | 214,000 | 214,000 | 242,845 | 242,845 |
Reference price 2 | 3.280 | 2.350 | 3.620 | 2.790 | 1.590 | 0.8800 |
Announcement Date | 4/18/18 | 4/25/19 | 4/28/20 | 4/29/21 | 4/28/22 | 4/26/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 483.7 | 358 | 341.8 | 155.4 | 160.9 | 144.6 |
EBITDA 1 | -34.2 | 4.077 | -32.7 | -146.3 | -56.79 | -28.95 |
EBIT 1 | -42.27 | 0.379 | -37.06 | -148.9 | -58.2 | -30.06 |
Operating Margin | -8.74% | 0.11% | -10.84% | -95.82% | -36.17% | -20.79% |
Earnings before Tax (EBT) 1 | -42.93 | 6.583 | -67.45 | -172.7 | -69.14 | 4.104 |
Net income 1 | -43.44 | -1.749 | -60.92 | -151.9 | -60.76 | 9.613 |
Net margin | -8.98% | -0.49% | -17.83% | -97.75% | -37.76% | 6.65% |
EPS 2 | -0.2172 | -0.008260 | -0.2847 | -0.7097 | -0.2619 | 0.0396 |
Free Cash Flow 1 | 70.43 | 4.483 | 56.83 | 38.9 | 49.3 | -15.6 |
FCF margin | 14.56% | 1.25% | 16.63% | 25.04% | 30.64% | -10.79% |
FCF Conversion (EBITDA) | - | 109.96% | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/18/18 | 4/25/19 | 4/28/20 | 4/29/21 | 4/28/22 | 4/26/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 119 | 41.1 | 66.6 | 57.4 | 5.65 | 17.4 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -3.467 x | 10.09 x | -2.038 x | -0.3921 x | -0.0994 x | -0.6005 x |
Free Cash Flow 1 | 70.4 | 4.48 | 56.8 | 38.9 | 49.3 | -15.6 |
ROE (net income / shareholders' equity) | -23.2% | 3.02% | -32.7% | -189% | -585% | 19.7% |
ROA (Net income/ Total Assets) | -6.83% | 0.07% | -6.94% | -38.7% | -21.5% | -10.6% |
Assets 1 | 635.8 | -2,524 | 877.5 | 392.5 | 282.5 | -90.28 |
Book Value Per Share 2 | 0.8300 | 1.030 | 0.7500 | 0.0500 | 0.0900 | 0.1400 |
Cash Flow per Share 2 | 0.1200 | 0.1300 | 0.2200 | 0.1300 | 0.1100 | 0.1400 |
Capex 1 | 2.26 | 1.7 | 2.77 | 3.09 | 1.08 | 0.89 |
Capex / Sales | 0.47% | 0.48% | 0.81% | 1.99% | 0.67% | 0.61% |
Announcement Date | 4/18/18 | 4/25/19 | 4/28/20 | 4/29/21 | 4/28/22 | 4/26/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-6.25% | 9.32M | |
+17.83% | 4.75B | |
+65.36% | 3.95B | |
-10.91% | 3.71B | |
+119.91% | 2.39B | |
+9.53% | 1.15B | |
+2.84% | 738M | |
-17.97% | 411M | |
+3.60% | 203M | |
-31.82% | 101M |
- Stock Market
- Equities
- 1255 Stock
- Financials TATA Health International Holdings Limited